![News outlet logo for favicons/hourdetroit.com.png](https://news.wayne.edu/storage/favicons/hourdetroit.com.png)
HOUR Detroit health feature references Dr. Kezhong Zhang's liver disease research
An article examining the causes of non-alcoholic steatohepatitis, a liver disease commonly called "NASH" that can turn into cirrhosis, includes medical opinions and analysis from Detroit-area doctors. Dr. Kezhong Zhang, a Wayne State University molecular medicine researcher who received a $1.7-million grant to further study a fat-controlling protein, suspects that abnormal fat metabolization may be the culprit. Zhang believes the protein, CREBH, is closely associated with fat building up in the liver, and with fatty liver's progression to NASH. He's trying to figure out how that happens and learn how to control the protein, possibly leading to a medication to treat NASH.